Orion Portfolio Solutions’s Maravai LifeSciences MRVI Stock Holding History

Orion Portfolio Solutions’s Portfolio MRVI Stock Details MRVI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$529K	Buy	239,357 +142,665	+148%	+$564K	0.01%	1398
2024 Q4	$527K	Sell	96,692 -39,057	-29%	-$251K	0.01%	1332
2024 Q3	$1.13M	Buy	135,749 +6,177	+5%	+$53.4K	0.01%	990
2024 Q2	$928K	Buy	129,572 +14,333	+12%	+$124K	0.01%	1026
2024 Q1	$999K	Buy	115,239 +14,519	+14%	+$98.2K	0.01%	983
2023 Q4	$692K	Buy	100,720 +35,564	+55%	+$230K	0.01%	1091
2023 Q3	$652K	Buy	65,156 +11,564	+22%	+$127K	0.01%	1100
2023 Q2	$666K	Buy	53,592 +22,833	+74%	+$308K	0.01%	1104
2023 Q1	$431K	Buy	+30,759	New	+$442K	0.01%	1191

Other funds holding MRVI

GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return

1WCM

12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

MFS

Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Orion Portfolio Solutions's MRVI Position: Q1 2025 in Review

Orion Portfolio Solutions increased its Maravai LifeSciences (MRVI) stake by 148% in Q1 2025, buying an estimated $564K and bringing the position to 239,357 shares worth $529K. The position accounts for 0.01% of the portfolio, ranked #1398.

Orion Portfolio Solutions first reported a position in MRVI in Q1 2023 and has held it in 9 quarters since. The position peaked at $1.13M in Q3 2024. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

Orion Portfolio Solutions held 239,357 shares of Maravai LifeSciences worth $529K as of Q1 2025.
Orion Portfolio Solutions bought 142,665 Maravai LifeSciences shares in Q1 2025, an estimated $564K.
Maravai LifeSciences made up 0.01% of Orion Portfolio Solutions's portfolio in Q1 2025, its #1398 holding.
Orion Portfolio Solutions first reported a position in Maravai LifeSciences in Q1 2023 and has held it in 9 quarters since.
Orion Portfolio Solutions's Maravai LifeSciences position peaked at $1.13M in Q3 2024.
184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Orion Portfolio Solutions's 13F filing for Q1 2025, filed 14 May 2025.